Stock offerings
Median Technologies Secures €23.9 Million Capital Increase Amid Expansion Plans
Median Technologies, the manufacturer of the eyonis(r) suite of artificial intelligence (AI) powered Software as a Medical Device for early cancer diagnosis, has successfully completed a capital increase of €23.9 million. This significant funding will enable the company to meet the contractual conditions for a €19 million EIB